Substituted Pyridazin-3(2 H)-ones as Highly Potent and Biased Formyl Peptide Receptor Agonists.

Abstract:

:Herein we describe the development of a focused series of functionalized pyridazin-3(2 H)-one-based formyl peptide receptor (FPR) agonists that demonstrate high potency and biased agonism. The compounds described demonstrated biased activation of prosurvival signaling, ERK1/2 phosphorylation, through diminution of the detrimental FPR1/2-mediated intracellular calcium (Cai2+) mobilization. Compound 50 showed an EC50 of 0.083 μM for phosphorylation of ERK1/2 and an approximate 20-fold bias away from Cai2+ mobilization at the hFPR1.

journal_name

J Med Chem

authors

Deora GS,Qin CX,Vecchio EA,Debono AJ,Priebbenow DL,Brady RM,Beveridge J,Teguh SC,Deo M,May LT,Krippner G,Ritchie RH,Baell JB

doi

10.1021/acs.jmedchem.8b01912

subject

Has Abstract

pub_date

2019-05-23 00:00:00

pages

5242-5248

issue

10

eissn

0022-2623

issn

1520-4804

journal_volume

62

pub_type

杂志文章